The second pathway is the impairment of brain Pi homeostasis, either by hyperphosphatemia or by disrupted transport of phosphate in the brain; these patients suffering from this pathway defects may have mutations in SLC20A2, XPR1, or GNAS gene7,8,27 and usually show significantly increased CSF Pi levels. Here, XPR1 is linked to hyperphosphatemia.